Actually the medicine stops hepatitis C virus to develop in the human body. The medicine is used only together with other antiviral drugs to cope with hepatitis infection in adult patients. Ribavirin manufactured under brands Copegus and Rebetol, Ribasphere, RibaTab with or without peginterferon alfa manufactured under brands Pegasys and PegIntron are often used in combination with Sovaldi.
Sovaldi can also be used together with Daklinza (daclatasvir) for the management of hepatitis C in patients with genotype 3.
Sovaldi is a treatment for patients who also have liver transplant and liver cancer.
The treatment with Sovaldi along with other drugs should be started with an approval of a doctor. Pregnant women must not use the combination therapy due to increased birth defects risks related to ribavirin use.
As with other medicines Sovaldi treatment should be started only when your medical professional tells you so. Before the treatment you should inform your doctor about any type of health condition or disease you have and any drug you take. It is important to tell your doctor if you have previously had allergic reactions to the medicines.
Patients with kidney or liver malfunction may need special tests to undergo before the treatment is initiated. Women should make a pregnancy test before using Sovaldi. Breast-feeding women are recommended to stop feeding their babies before and during the treatment with Sovaldi.
Sovaldi must be consumed once per day in the dose of 400 mg. The pill of the medicine should not be missed or skipped. Regular intake will provide more beneficial results. Food intake does not influence on the action of the medicine.
During the treatment a patient needs to make blood tests. This should not be neglected as a doctor can estimate the progress and correct the treatment somehow if necessary.
Usually the therapy lasts from 12 to 24 weeks depending on the genotype of Hepatitis C. Patients with liver transplant require longer treatment up to 48 weeks.
The medicine was carefully tested and proven to be very effective during clinical studies. The success rates are very great along with low risks for side effects.
Sovaldi is approved by the FDA for the treatment of Hepatitis C in combination with other medicines.
The allergic reactions to Sovaldi may include serious ones. A patient should immediately call an emergency medical help. Other serious side effects are: short of breath, irregular heart beat, fainting, painful mouth sores and others.
However the medicine is well tolerated producing minor or mild side effects in a few patients.